%0 Journal Article
%T Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes
%A Luca A Lotta
%A Mark Wang
%A Jin Yu
%A Ida Martinelli
%A Fuli Yu
%A Serena M Passamonti
%A Dario Consonni
%A Emanuela Pappalardo
%A Marzia Menegatti
%A Steven E Scherer
%A Lora L Lewis
%A Humeira Akbar
%A Yuanqing Wu
%A Matthew N Bainbridge
%A Donna M Muzny
%A Pier M Mannucci
%A Richard A Gibbs
%A Flora Peyvandi
%J BMC Medical Genomics
%D 2012
%I BioMed Central
%R 10.1186/1755-8794-5-7
%X A molecular-barcoding strategy was used to multiplex DNA target capture and sequencing, while retaining individual sequence information. Genomic libraries with barcode sequence-tags were pooled (in pools of 8 or 16 samples) and enriched for target DNA sequences. Sequencing was performed on ABI SOLiD-4 platforms. We produced > 12 gigabases of raw sequence data to sequence at high coverage (average: 42X) the 700-kilobase target area in 22 individuals. A total of 1876 high-quality genetic variants were identified (1778 single nucleotide substitutions and 98 insertions/deletions). Annotation on databases of genetic variation and human disease mutations revealed several novel, potentially deleterious mutations. We tested 576 common variants in a case-control association analysis, carrying the top-5 associations over to replication in up to 719 DVT cases and 719 controls. We also conducted an analysis of the burden of nonsynonymous variants in coagulation factor and anticoagulant genes. We found an excess of rare missense mutations in anticoagulant genes in DVT cases compared to controls and an association for a missense polymorphism of FGA (rs6050; p = 1.9 กม 10-5, OR 1.45; 95% CI, 1.22-1.72; after replication in > 1400 individuals).We implemented a barcode-based strategy to efficiently multiplex sequencing of hundreds of candidate genes in several individuals. In the relatively small dataset of our pilot study we were able to identify bona fide associations with DVT. Our study illustrates the potential of next-generation sequencing for the discovery of genetic variation predisposing to complex diseases.Deep vein thrombosis (DVT) of the lower extremities, a common thrombotic disease often complicated by acute pulmonary embolism [1], has a strong genetic component as established by family [2-4] and twin studies [5], with a 3-fold increase in disease risk for siblings of individuals with DVT [2] and an estimated hereditary component of 60% [3]. Genetic risk factors include
%K Deep vein thrombosis
%K venous thromboembolism
%K next-generation sequencing
%K target capture
%K multiplexing
%K FGA
%K rs6025
%K heamostateome
%K DVT
%K VTE
%U http://www.biomedcentral.com/1755-8794/5/7